Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Rituximab Combined With Prednisone for the Initial Treatment of Chronic Graft Versus Host Disease

NCT01066598 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT01066598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01066598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Rituximab Combined With Prednisone for the Initial Treatment of Chronic Graft Versus Host Disease
Lead sponsor
University Health Network, Toronto
Phase
Phase 2
Overall status
Terminated
Start date
May 31, 2010
Completion date
August 31, 2011
Enrollment
1 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

graft versus host disease